NCT00814177View on ClinicalTrials.gov

Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

April 30, 2009

Conditions

Atrial FibrillationVenous ThromboembolismIschemic StrokeMyocardial Infarction

Interventions

DRUG

warfarin

No change: Continue without any change in spite of prothrombin time outside the therapeutic range.

DRUG

warfarin

Change: Increase one dose in case prothrombin time is below the therapeutic range; delete or reduce one dose in case prothrombin time is above the therapeutic range.

Trial Locations (1)

L8L 2X2

Thrombosis Service, HHS-General Hospital, Hamilton

All Listed Sponsors

lead

Hamilton Health Sciences Corporation

OTHER

NCT00814177 - Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients | Biotech Hunter | Biotech Hunter